🔗 Share this article

The prestigious award in medical science has been granted for transformative discoveries that illuminate how the immune system attacks harmful pathogens while sparing the healthy tissues.

A trio of esteemed scientists—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—share this honor.

The research identified unique "sentinels" within the immune system that eliminate rogue defense cells capable of attacking the body.

These findings are now enabling new therapies for autoimmune diseases and cancer.

These laureates will divide a monetary award worth 11 million SEK.

Crucial Findings

"The work has been decisive for comprehending how the immune system operates and the reason we do not all suffer from serious self-attack conditions," commented the chair of the award panel.

This trio's studies explain a core question: In what way does the immune system defend us from countless invaders while leaving our healthy cells intact?

Our body's protection system uses white blood cells that scan for signs of disease, including pathogens and bacteria it has not met before.

Such defenders utilize detectors—called recognition units—that are produced by chance in a vast number of combinations.

This provides the defense network the ability to combat a wide array of invaders, but the unpredictability of the process unavoidably creates immune cells that can attack the host.

Protectors of the Immune System

Scientists earlier understood that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells mature.

This year's award recognizes the discovery of regulatory T-cells—known as the body's "security guards"—which patrol the body to neutralize any immune cells that assault the body's own tissues.

We know that this process fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

The Nobel panel added, "The findings have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for instance for cancer and immune disorders."

Regarding cancer, regulatory T-cells block the body from fighting the growth, so research are aimed at reducing their quantity.

In autoimmune diseases, trials are testing boosting T-reg cells so the body is not under attack. A similar approach could also be useful in minimizing the risks of transplanted organ rejection.

Pioneering Studies

Prof Sakaguchi, from a Japanese institution, conducted tests on mice that had their immune gland removed, leading to self-attack conditions.

The researcher showed that introducing immune cells from other animals could stop the disease—implying there was a mechanism for preventing defenders from harming the body.

Mary Brunkow, from the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an genetic autoimmune disease in rodents and humans that led to the identification of a genetic factor vital for how T-regs operate.

"The groundbreaking work has uncovered how the immune system is controlled by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a leading physiology specialist.

"This work is a striking illustration of how fundamental biological research can have far-reaching implications for human health."